<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37834270</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>19</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Dynamics of the Microbiota and Its Relationship with Post-COVID-19 Syndrome.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">14822</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms241914822</ELocationID><Abstract><AbstractText>Coronavirus disease (COVID-19) is an infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which can be asymptomatic or present with multiple organ dysfunction. Many infected individuals have chronic alterations associated with neuropsychiatric, endocrine, gastrointestinal, and musculoskeletal symptoms, even several months after disease onset, developing long-COVID or post-acute COVID-19 syndrome (PACS). Microbiota dysbiosis contributes to the onset and progression of many viral diseases, including COVID-19 and post-COVID-19 manifestations, which could serve as potential diagnostic and prognostic biomarkers. This review aimed to discuss the most recent findings on gut microbiota dysbiosis and its relationship with the sequelae of PACS. Elucidating these mechanisms could help develop personalized and non-invasive clinical strategies to identify individuals at a higher risk of experiencing severe disease progression or complications associated with PACS. Moreover, the review highlights the importance of targeting the gut microbiota composition to avoid dysbiosis and to develop possible prophylactic and therapeutic measures against COVID-19 and PACS in future studies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moreno-Corona</LastName><ForeName>Nidia Carolina</ForeName><Initials>NC</Initials><Identifier Source="ORCID">0000-0001-5248-0454</Identifier><AffiliationInfo><Affiliation>Laboratory of Human Lymphohematopoiesis, Imagine Institute, INSERM UMR 1163, Universit&#xe9; de Paris, 75015 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-Ortega</LastName><ForeName>Orestes</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-0319-1661</Identifier><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9;, INSERM UMR-S1151, CNRS UMR-S8253, Institute Necker Enfants Malades, 75015 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;rez-Mart&#xed;nez</LastName><ForeName>Cesar Augusto</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Departamento de F&#xed;sica, Universidad de Sonora, Hermosillo 83000, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez-Castillo</LastName><ForeName>Macario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Secci&#xf3;n de Estudios de Posgrado e Investigaci&#xf3;n, Escuela Superior de Medicina, Instituto Polit&#xe9;cnico Nacional, Mexico City 11340, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Jes&#xfa;s-Gonz&#xe1;lez</LastName><ForeName>Luis Adri&#xe1;n</ForeName><Initials>LA</Initials><Identifier Source="ORCID">0000-0003-1415-6260</Identifier><AffiliationInfo><Affiliation>Unidad de Investigaci&#xf3;n Biom&#xe9;dica de Zacatecas, Instituto Mexicano del Seguro Social, Zacatecas 98000, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le&#xf3;n-Reyes</LastName><ForeName>Guadalupe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Laboratorio de Nutrigen&#xe9;tica y Nutrigen&#xf3;mica, Instituto Nacional de Medicina Gen&#xf3;mica (INMEGEN), M&#xe9;xico City 16610, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le&#xf3;n-Ju&#xe1;rez</LastName><ForeName>Mois&#xe9;s</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5726-5953</Identifier><AffiliationInfo><Affiliation>Laboratorio de Virolog&#xed;a Perinatal y Dise&#xf1;o Molecular de Ant&#xed;genos y Biomarcadores, Departamento de Inmunobioqu&#xed;mica, Instituto Nacional de Perinatolog&#xed;a, Mexico City 11000, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064806" MajorTopicYN="N">Dysbiosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064307" MajorTopicYN="Y">Microbiota</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">gut microbiota</Keyword><Keyword MajorTopicYN="N">long COVID-19</Keyword><Keyword MajorTopicYN="N">post-acute COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">virus infection</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>1</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>14</Day><Hour>10</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>14</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37834270</ArticleId><ArticleId IdType="pmc">PMC10573029</ArticleId><ArticleId IdType="doi">10.3390/ijms241914822</ArticleId><ArticleId IdType="pii">ijms241914822</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Da Rosa Mesquita R., Francelino Silva Junior L.C., Santos Santana F.M., Farias De Oliveira T., Campos Alc&#xe2;ntara R., Monteiro Arnozo G., Rodrigues Da Silva Filho E., Galdino Dos Santos A.G., Oliveira Da Cunha E.J., Salgueiro De Aquino S.H., et al. Clinical Manifestations of COVID-19 in the General Population: Systematic Review. Wien. Klin. Wochenschr. 2021;133:377&#x2013;382. doi: 10.1007/s00508-020-01760-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00508-020-01760-4</ArticleId><ArticleId IdType="pmc">PMC7689634</ArticleId><ArticleId IdType="pubmed">33242148</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institutes of Health COVID-19 Treatment Guidelines Panel . Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health; Bethesda, MD, USA: 2023.</Citation><ArticleIdList><ArticleId IdType="pubmed">34003615</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B., Zhang L., Wang Y., Dai T., Qin Z., Zhou F., Zhang L. Alterations in Microbiota of Patients with COVID-19: Potential Mechanisms and Therapeutic Interventions. Signal Transduct. Target. Ther. 2022;7:143. doi: 10.1038/s41392-022-00986-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00986-0</ArticleId><ArticleId IdType="pmc">PMC9052735</ArticleId><ArticleId IdType="pubmed">35487886</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-Acute COVID-19 Syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Maltezou H.C., Pavli A., Tsakris A. Post-COVID Syndrome: An Insight on Its Pathogenesis. Vaccines. 2021;9:497. doi: 10.3390/vaccines9050497.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9050497</ArticleId><ArticleId IdType="pmc">PMC8151752</ArticleId><ArticleId IdType="pubmed">34066007</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Mak J.W.Y., Su Q., Yeoh Y.K., Lui G.C.-Y., Ng S.S.S., Zhang F., Li A.Y.L., Lu W., Hui D.S.-C., et al. Gut Microbiota Dynamics in a Prospective Cohort of Patients with Post-Acute COVID-19 Syndrome. Gut. 2022;71:544&#x2013;552. doi: 10.1136/gutjnl-2021-325989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Rastogi S., Mohanty S., Sharma S., Tripathi P. Possible Role of Gut Microbes and Host&#x2019;s Immune Response in Gut&#x2013;Lung Homeostasis. Front. Immunol. 2022;13:954339. doi: 10.3389/fimmu.2022.954339.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.954339</ArticleId><ArticleId IdType="pmc">PMC9581402</ArticleId><ArticleId IdType="pubmed">36275735</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu R., Lu R., Zhang T., Wu Q., Cai W., Han X., Wan Z., Jin X., Zhang Z., Zhang C. Temporal Association between Human Upper Respiratory and Gut Bacterial Microbiomes during the Course of COVID-19 in Adults. Commun. Biol. 2021;4:240. doi: 10.1038/s42003-021-01796-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-01796-w</ArticleId><ArticleId IdType="pmc">PMC7893062</ArticleId><ArticleId IdType="pubmed">33603076</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez-Ter&#xe1;n A., Mej&#xed;a-Nepomuceno F., Herrera M.T., Barreto O., Garc&#xed;a E., Castillejos M., Boukadida C., Matias-Florentino M., Rinc&#xf3;n-Rubio A., Avila-Rios S., et al. Dysbiosis and Structural Disruption of the Respiratory Microbiota in COVID-19 Patients with Severe and Fatal Outcomes. Sci. Rep. 2021;11:21297. doi: 10.1038/s41598-021-00851-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-00851-0</ArticleId><ArticleId IdType="pmc">PMC8556282</ArticleId><ArticleId IdType="pubmed">34716394</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T., Zhang F., Lui G.C.Y., Yeoh Y.K., Li A.Y.L., Zhan H., Wan Y., Chung A.C.K., Cheung C.P., Chen N., et al. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization. Gastroenterology. 2020;159:944&#x2013;955.e8. doi: 10.1053/j.gastro.2020.05.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.048</ArticleId><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizutani T., Ishizaka A., Koga M., Ikeuchi K., Saito M., Adachi E., Yamayoshi S., Iwatsuki-Horimoto K., Yasuhara A., Kiyono H., et al. Correlation Analysis between Gut Microbiota Alterations and the Cytokine Response in Patients with Coronavirus Disease during Hospitalization. Microbiol. Spectr. 2022;10:e01689-21. doi: 10.1128/spectrum.01689-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.01689-21</ArticleId><ArticleId IdType="pmc">PMC9045125</ArticleId><ArticleId IdType="pubmed">35254122</ArticleId></ArticleIdList></Reference><Reference><Citation>Gang J., Wang H., Xue X., Zhang S. Microbiota and COVID-19: Long-Term and Complex Influencing Factors. Front. Microbiol. 2022;13:963488. doi: 10.3389/fmicb.2022.963488.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.963488</ArticleId><ArticleId IdType="pmc">PMC9417543</ArticleId><ArticleId IdType="pubmed">36033885</ArticleId></ArticleIdList></Reference><Reference><Citation>Schult D., Reitmeier S., Koyumdzhieva P., Lahmer T., Middelhoff M., Erber J., Schneider J., Kager J., Frolova M., Horstmann J., et al. Gut Bacterial Dysbiosis and Instability Is Associated with the Onset of Complications and Mortality in COVID-19. Gut Microbes. 2022;14:2031840. doi: 10.1080/19490976.2022.2031840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2022.2031840</ArticleId><ArticleId IdType="pmc">PMC8855857</ArticleId><ArticleId IdType="pubmed">35174781</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Zhang J., Zhang D., Ma W.-L., Wang X. Linking the Gut Microbiota to Persistent Symptoms in Survivors of COVID-19 after Discharge. J. Microbiol. 2021;59:941&#x2013;948. doi: 10.1007/s12275-021-1206-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12275-021-1206-5</ArticleId><ArticleId IdType="pmc">PMC8356893</ArticleId><ArticleId IdType="pubmed">34382150</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh Y.K., Zuo T., Lui G.C.-Y., Zhang F., Liu Q., Li A.Y., Chung A.C., Cheung C.P., Tso E.Y., Fung K.S., et al. Gut Microbiota Composition Reflects Disease Severity and Dysfunctional Immune Responses in Patients with COVID-19. Gut. 2021;70:698&#x2013;706. doi: 10.1136/gutjnl-2020-323020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazan S., Stollman N., Bozkurt H.S., Dave S., Papoutsis A.J., Daniels J., Barrows B.D., Quigley E.M., Borody T.J. Lost Microbes of COVID-19: Bifidobacterium, Faecalibacterium Depletion and Decreased Microbiome Diversity Associated with SARS-CoV-2 Infection Severity. BMJ Open Gastroenterol. 2022;9:e000871. doi: 10.1136/bmjgast-2022-000871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgast-2022-000871</ArticleId><ArticleId IdType="pmc">PMC9051551</ArticleId><ArticleId IdType="pubmed">35483736</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or Post-Acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front. Microbiol. 2021;12:698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavli A., Theodoridou M., Maltezou H.C. Post-COVID Syndrome: Incidence, Clinical Spectrum, and Challenges for Primary Healthcare Professionals. Arch. Med. Res. 2021;52:575&#x2013;581. doi: 10.1016/j.arcmed.2021.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2021.03.010</ArticleId><ArticleId IdType="pmc">PMC8093949</ArticleId><ArticleId IdType="pubmed">33962805</ArticleId></ArticleIdList></Reference><Reference><Citation>Post COVID-19 Condition (Long Covid)  [(accessed on 11 November 2022)].  Available online:  Https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-clinical_case_definition-2021.1.</Citation></Reference><Reference><Citation>Petersen M.S., Kristiansen M.F., Hanusson K.D., Foldbo B.M., Danielsen M.E., &#xe1; Steig B., Gaini S., Str&#xf8;m M., Weihe P. Prevalence of Long COVID in a National Cohort: Longitudinal Measures from Disease Onset until 8 Months&#x2019; Follow-Up. Int. J. Infect. Dis. 2022;122:437&#x2013;441. doi: 10.1016/j.ijid.2022.06.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.06.031</ArticleId><ArticleId IdType="pmc">PMC9222150</ArticleId><ArticleId IdType="pubmed">35753603</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Sampalo A., Bernal-L&#xf3;pez M.R., G&#xf3;mez-Huelgas R. S&#xed;ndrome de COVID-19 persistente. Una revisi&#xf3;n narrativa. Rev. Cl&#xed;nica Esp. 2022;222:241&#x2013;250. doi: 10.1016/j.rce.2021.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rce.2021.10.003</ArticleId><ArticleId IdType="pmc">PMC8590955</ArticleId><ArticleId IdType="pubmed">34803180</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., Madhavan M.V., Sehgal K., Nair N., Mahajan S., Sehrawat T.S., Bikdeli B., Ahluwalia N., Ausiello J.C., Wan E.Y., et al. Extrapulmonary Manifestations of COVID-19. Nat. Med. 2020;26:1017&#x2013;1032. doi: 10.1038/s41591-020-0968-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai A.D., Lavelle M., Boursiquot B.C., Wan E.Y. Long-Term Complications of COVID-19. Am. J. Physiol.-Cell Physiol. 2022;322:C1&#x2013;C11. doi: 10.1152/ajpcell.00375.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00375.2021</ArticleId><ArticleId IdType="pmc">PMC8721906</ArticleId><ArticleId IdType="pubmed">34817268</ArticleId></ArticleIdList></Reference><Reference><Citation>Carod Artal F.J. S&#xed;ndrome post-COVID-19: Epidemiolog&#xed;a, criterios diagn&#xf3;sticos y mecanismos patog&#xe9;nicos implicados. Rev. Neurol. 2021;72:384. doi: 10.33588/rn.7211.2021230.</Citation><ArticleIdList><ArticleId IdType="doi">10.33588/rn.7211.2021230</ArticleId><ArticleId IdType="pubmed">34042167</ArticleId></ArticleIdList></Reference><Reference><Citation>Brightling C.E., Evans R.A. Long COVID: Which Symptoms Can Be Attributed to SARS-CoV-2 Infection? Lancet. 2022;400:411&#x2013;413. doi: 10.1016/S0140-6736(22)01385-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01385-X</ArticleId><ArticleId IdType="pmc">PMC9352303</ArticleId><ArticleId IdType="pubmed">35933996</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q., Zheng B., Daines L., Sheikh A. Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms. Pathogens. 2022;11:269. doi: 10.3390/pathogens11020269.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli C., Zocchi C., Tassetti L., Silverii M.V., Amato C., Livi L., Giovannoni L., Verrillo F., Bartoloni A., Marcucci R., et al. Factors Associated with Persistence of Symptoms 1 Year after COVID-19: A Longitudinal, Prospective Phone-Based Interview Follow-up Cohort Study. Eur. J. Intern. Med. 2022;97:36&#x2013;41. doi: 10.1016/j.ejim.2021.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.11.018</ArticleId><ArticleId IdType="pmc">PMC8648678</ArticleId><ArticleId IdType="pubmed">34903448</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J., Liu S. Proposed Subtypes of post-COVID-19 Syndrome (or long-COVID) and Their Respective Potential Therapies. Rev. Med. Virol. 2022;32:e2315. doi: 10.1002/rmv.2315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2315</ArticleId><ArticleId IdType="pubmed">34888989</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgiou K., Marinov B., Farooqi A.A., Gazouli M. Gut Microbiota in Lung Cancer: Where Do We Stand? Int. J. Mol. Sci. 2021;22:10429. doi: 10.3390/ijms221910429.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms221910429</ArticleId><ArticleId IdType="pmc">PMC8508914</ArticleId><ArticleId IdType="pubmed">34638770</ArticleId></ArticleIdList></Reference><Reference><Citation>Chunxi L., Haiyue L., Yanxia L., Jianbing P., Jin S. The Gut Microbiota and Respiratory Diseases: New Evidence. J. Immunol. Res. 2020;2020:2340670. doi: 10.1155/2020/2340670.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/2340670</ArticleId><ArticleId IdType="pmc">PMC7415116</ArticleId><ArticleId IdType="pubmed">32802893</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou K., Wu Z.-X., Chen X.-Y., Wang J.-Q., Zhang D., Xiao C., Zhu D., Koya J.B., Wei L., Li J., et al. Microbiota in Health and Diseases. Signal Transduct. Target. Ther. 2022;7:135. doi: 10.1038/s41392-022-00974-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00974-4</ArticleId><ArticleId IdType="pmc">PMC9034083</ArticleId><ArticleId IdType="pubmed">35461318</ArticleId></ArticleIdList></Reference><Reference><Citation>Invernizzi R., Lloyd C.M., Molyneaux P.L. Respiratory Microbiome and Epithelial Interactions Shape Immunity in the Lungs. Immunology. 2020;160:171&#x2013;182. doi: 10.1111/imm.13195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.13195</ArticleId><ArticleId IdType="pmc">PMC7218407</ArticleId><ArticleId IdType="pubmed">32196653</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommariva M., Le Noci V., Bianchi F., Camelliti S., Balsari A., Tagliabue E., Sfondrini L. The Lung Microbiota: Role in Maintaining Pulmonary Immune Homeostasis and Its Implications in Cancer Development and Therapy. Cell. Mol. Life Sci. CMLS. 2020;77:2739&#x2013;2749. doi: 10.1007/s00018-020-03452-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-020-03452-8</ArticleId><ArticleId IdType="pmc">PMC7326824</ArticleId><ArticleId IdType="pubmed">31974656</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph S.W., Carnahan A., Rollins D., Walker R.I. Aeromonas and Plesiomonas in the Environment: Value of Differential Biotyping of Aeromonads. J. Diarrhoeal Dis. Res. 1988;6:80&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">3077630</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang A.T., Marsland B.J. Microbes, Metabolites, and the Gut-Lung Axis. Mucosal Immunol. 2019;12:843&#x2013;850. doi: 10.1038/s41385-019-0160-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-019-0160-6</ArticleId><ArticleId IdType="pubmed">30976087</ArticleId></ArticleIdList></Reference><Reference><Citation>McAleer J.P., Nguyen N.L.H., Chen K., Kumar P., Ricks D.M., Binnie M., Armentrout R.A., Pociask D.A., Hein A., Yu A., et al. Pulmonary Th17 Antifungal Immunity Is Regulated by the Gut Microbiome. J. Immunol. 2016;197:97&#x2013;107. doi: 10.4049/jimmunol.1502566.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1502566</ArticleId><ArticleId IdType="pmc">PMC4912941</ArticleId><ArticleId IdType="pubmed">27217583</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Tian Z. How Lung Infection Leads to Gut Injury. Oncotarget. 2015;6:42394&#x2013;42395. doi: 10.18632/oncotarget.6470.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.6470</ArticleId><ArticleId IdType="pmc">PMC4767440</ArticleId><ArticleId IdType="pubmed">26646453</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou A., Lei Y., Tang L., Hu S., Yang M., Wu L., Yang S., Tang B. Gut Microbiota: The Emerging Link to Lung Homeostasis and Disease. J. Bacteriol. 2021;203:e00454-20. doi: 10.1128/JB.00454-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JB.00454-20</ArticleId><ArticleId IdType="pmc">PMC7847545</ArticleId><ArticleId IdType="pubmed">33077630</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Liu J.-S., Peng S.-H., Deng X.-Y., Zhu D.-M., Javidiparsijani S., Wang G.-R., Li D.-Q., Li L.-X., Wang Y.-C., et al. Gut-Lung Crosstalk in Pulmonary Involvement with Inflammatory Bowel Diseases. World, J. Gastroenterol. 2013;19:6794&#x2013;6804. doi: 10.3748/wjg.v19.i40.6794.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v19.i40.6794</ArticleId><ArticleId IdType="pmc">PMC3812478</ArticleId><ArticleId IdType="pubmed">24187454</ArticleId></ArticleIdList></Reference><Reference><Citation>Harper A., Vijayakumar V., Ouwehand A.C., ter Haar J., Obis D., Espadaler J., Binda S., Desiraju S., Day R. Viral Infections, the Microbiome, and Probiotics. Front. Cell. Infect. Microbiol. 2021;10:596166. doi: 10.3389/fcimb.2020.596166.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.596166</ArticleId><ArticleId IdType="pmc">PMC7907522</ArticleId><ArticleId IdType="pubmed">33643929</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizutani T., Ishizaka A., Koga M., Tsutsumi T., Yotsuyanagi H. Role of Microbiota in Viral Infections and Pathological Progression. Viruses. 2022;14:950. doi: 10.3390/v14050950.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14050950</ArticleId><ArticleId IdType="pmc">PMC9144409</ArticleId><ArticleId IdType="pubmed">35632692</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosch A.A.T.M., Biesbroek G., Trzcinski K., Sanders E.A.M., Bogaert D. Viral and Bacterial Interactions in the Upper Respiratory Tract. PLoS Pathog. 2013;9:e1003057. doi: 10.1371/journal.ppat.1003057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003057</ArticleId><ArticleId IdType="pmc">PMC3542149</ArticleId><ArticleId IdType="pubmed">23326226</ArticleId></ArticleIdList></Reference><Reference><Citation>Man W.H., de Steenhuijsen Piters W.A.A., Bogaert D. The Microbiota of the Respiratory Tract: Gatekeeper to Respiratory Health. Nat. Rev. Microbiol. 2017;15:259&#x2013;270. doi: 10.1038/nrmicro.2017.14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro.2017.14</ArticleId><ArticleId IdType="pmc">PMC7097736</ArticleId><ArticleId IdType="pubmed">28316330</ArticleId></ArticleIdList></Reference><Reference><Citation>Ormerod K.L., Wood D.L.A., Lachner N., Gellatly S.L., Daly J.N., Parsons J.D., Dal&#x2019;Molin C.G.O., Palfreyman R.W., Nielsen L.K., Cooper M.A., et al. Genomic Characterization of the Uncultured Bacteroidales Family S24-7 Inhabiting the Guts of Homeothermic Animals. Microbiome. 2016;4:36. doi: 10.1186/s40168-016-0181-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-016-0181-2</ArticleId><ArticleId IdType="pmc">PMC4936053</ArticleId><ArticleId IdType="pubmed">27388460</ArticleId></ArticleIdList></Reference><Reference><Citation>den Besten G., van Eunen K., Groen A.K., Venema K., Reijngoud D.-J., Bakker B.M. The Role of Short-Chain Fatty Acids in the Interplay between Diet, Gut Microbiota, and Host Energy Metabolism. J. Lipid Res. 2013;54:2325&#x2013;2340. doi: 10.1194/jlr.R036012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.R036012</ArticleId><ArticleId IdType="pmc">PMC3735932</ArticleId><ArticleId IdType="pubmed">23821742</ArticleId></ArticleIdList></Reference><Reference><Citation>Woods Acevedo M.A., Pfeiffer J.K. Microbiota-Immune System Interactions and Enteric Virus Infection. Curr. Opin. Virol. 2021;46:15&#x2013;19. doi: 10.1016/j.coviro.2020.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2020.08.005</ArticleId><ArticleId IdType="pmc">PMC7933313</ArticleId><ArticleId IdType="pubmed">32898729</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng C., Jin C., Liu K., Yang Z. Microbiota-Derived Short Chain Fatty Acids: Their Role and Mechanisms in Viral Infections. Biomed. Pharmacother. 2023;160:114414. doi: 10.1016/j.biopha.2023.114414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2023.114414</ArticleId></ArticleIdList></Reference><Reference><Citation>Antunes K.H., Fachi J.L., de Paula R., da Silva E.F., Pral L.P., dos Santos A.&#xc1;., Dias G.B.M., Vargas J.E., Puga R., Mayer F.Q., et al. Microbiota-Derived Acetate Protects against Respiratory Syncytial Virus Infection through a GPR43-Type 1 Interferon Response. Nat. Commun. 2019;10:3273. doi: 10.1038/s41467-019-11152-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11152-6</ArticleId><ArticleId IdType="pmc">PMC6646332</ArticleId><ArticleId IdType="pubmed">31332169</ArticleId></ArticleIdList></Reference><Reference><Citation>Erttmann S.F., Swacha P., Aung K.M., Brindefalk B., Jiang H., H&#xe4;rtlova A., Uhlin B.E., Wai S.N., Gekara N.O. The Gut Microbiota Prime Systemic Antiviral Immunity via the cGAS-STING-IFN-I Axis. Immunity. 2022;55:847&#x2013;861.e10. doi: 10.1016/j.immuni.2022.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.04.006</ArticleId><ArticleId IdType="pubmed">35545033</ArticleId></ArticleIdList></Reference><Reference><Citation>Sencio V., Machado M.G., Trottein F. The Lung&#x2013;Gut Axis during Viral Respiratory Infections: The Impact of Gut Dysbiosis on Secondary Disease Outcomes. Mucosal Immunol. 2021;14:296&#x2013;304. doi: 10.1038/s41385-020-00361-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-020-00361-8</ArticleId><ArticleId IdType="pmc">PMC7835650</ArticleId><ArticleId IdType="pubmed">33500564</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv Z., Xiong D., Shi J., Long M., Chen Z. The Interaction Between Viruses and Intestinal Microbiota: A Review. Curr. Microbiol. 2021;78:3597&#x2013;3608. doi: 10.1007/s00284-021-02623-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00284-021-02623-5</ArticleId><ArticleId IdType="pmc">PMC8336530</ArticleId><ArticleId IdType="pubmed">34350485</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Winkle J.A., Peterson S.T., Kennedy E.A., Wheadon M.J., Ingle H., Desai C., Rodgers R., Constant D.A., Wright A.P., Li L., et al. Homeostatic Interferon-Lambda Response to Bacterial Microbiota Stimulates Preemptive Antiviral Defense within Discrete Pockets of Intestinal Epithelium. eLife. 2022;11:e74072. doi: 10.7554/eLife.74072.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.74072</ArticleId><ArticleId IdType="pmc">PMC8853662</ArticleId><ArticleId IdType="pubmed">35137688</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefan K.L., Kim M.V., Iwasaki A., Kasper D.L. Commensal Microbiota Modulation of Natural Resistance to Virus Infection. Cell. 2020;183:1312&#x2013;1324.e10. doi: 10.1016/j.cell.2020.10.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.047</ArticleId><ArticleId IdType="pmc">PMC7799371</ArticleId><ArticleId IdType="pubmed">33212011</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y., Wang J., Li F., Shi Y. Main Clinical Features of COVID-19 and Potential Prognostic and Therapeutic Value of the Microbiota in SARS-CoV-2 Infections. Front. Microbiol. 2020;11:1302. doi: 10.3389/fmicb.2020.01302.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.01302</ArticleId><ArticleId IdType="pmc">PMC7291771</ArticleId><ArticleId IdType="pubmed">32582134</ArticleId></ArticleIdList></Reference><Reference><Citation>Aan F.J., Glibetic N., Montoya-Uribe V., Matter M.L. Comprehensive Gut Microbiota. Elsevier; Amsterdam, The Netherlands: 2022. COVID-19 and the Microbiome: The Gut-Lung Connection; pp. 442&#x2013;458.</Citation></Reference><Reference><Citation>Gu S., Chen Y., Wu Z., Chen Y., Gao H., Lv L., Guo F., Zhang X., Luo R., Huang C., et al. Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza. Clin. Infect. Dis. 2020;71:2669&#x2013;2678. doi: 10.1093/cid/ciaa709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa709</ArticleId><ArticleId IdType="pmc">PMC7314193</ArticleId><ArticleId IdType="pubmed">32497191</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., Yang S., Zhou Y., Disoma C., Dong Z., Du A., Zhang Y., Chen Y., Huang W., Chen J., et al. Microbiome Profiling Using Shotgun Metagenomic Sequencing Identified Unique Microorganisms in COVID-19 Patients With Altered Gut Microbiota. Front. Microbiol. 2021;12:712081. doi: 10.3389/fmicb.2021.712081.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.712081</ArticleId><ArticleId IdType="pmc">PMC8542975</ArticleId><ArticleId IdType="pubmed">34707577</ArticleId></ArticleIdList></Reference><Reference><Citation>Stutz M.R., Dylla N.P., Pearson S.D., Lecompte-Osorio P., Nayak R., Khalid M., Adler E., Boissiere J., Lin H., Leiter W., et al. Immunomodulatory Fecal Metabolites Are Associated with Mortality in COVID-19 Patients with Respiratory Failure. Nat. Commun. 2022;13:6615. doi: 10.1038/s41467-022-34260-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34260-2</ArticleId><ArticleId IdType="pmc">PMC9633022</ArticleId><ArticleId IdType="pubmed">36329015</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard-Raichon L., Venzon M., Klein J., Axelrad J.E., Zhang C., Sullivan A.P., Hussey G.A., Casanovas-Massana A., Noval M.G., Valero-Jimenez A.M., et al. Gut Microbiome Dysbiosis in Antibiotic-Treated COVID-19 Patients Is Associated with Microbial Translocation and Bacteremia. Nat. Commun. 2022;13:5926. doi: 10.1038/s41467-022-33395-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33395-6</ArticleId><ArticleId IdType="pmc">PMC9626559</ArticleId><ArticleId IdType="pubmed">36319618</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F., Wan Y., Zuo T., Yeoh Y.K., Liu Q., Zhang L., Zhan H., Lu W., Xu W., Lui G.C.Y., et al. Prolonged Impairment of Short-Chain Fatty Acid and L-Isoleucine Biosynthesis in Gut Microbiome in Patients With COVID-19. Gastroenterology. 2022;162:548&#x2013;561.e4. doi: 10.1053/j.gastro.2021.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2021.10.013</ArticleId><ArticleId IdType="pmc">PMC8529231</ArticleId><ArticleId IdType="pubmed">34687739</ArticleId></ArticleIdList></Reference><Reference><Citation>Vestad B., Ueland T., Lerum T.V., Dahl T.B., Holm K., Barratt-Due A., K&#xe5;sine T., Dyrhol-Riise A.M., Stiksrud B., Tonby K., et al. Respiratory Dysfunction Three Months after Severe COVID-19 Is Associated with Gut Microbiota Alterations. J. Intern. Med. 2022;291:801&#x2013;812. doi: 10.1111/joim.13458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13458</ArticleId><ArticleId IdType="pmc">PMC9115297</ArticleId><ArticleId IdType="pubmed">35212063</ArticleId></ArticleIdList></Reference><Reference><Citation>Romani L., Del Chierico F., Macari G., Pane S., Ristori M.V., Guarrasi V., Gardini S., Pascucci G.R., Cotugno N., Perno C.F., et al. The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection. Front. Cell. Infect. Microbiol. 2022;12:908492. doi: 10.3389/fcimb.2022.908492.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.908492</ArticleId><ArticleId IdType="pmc">PMC9304937</ArticleId><ArticleId IdType="pubmed">35873161</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosca A., Leclerc M., Hugot J.P. Gut Microbiota Diversity and Human Diseases: Should We Reintroduce Key Predators in Our Ecosystem? Front. Microbiol. 2016;7:455. doi: 10.3389/fmicb.2016.00455.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2016.00455</ArticleId><ArticleId IdType="pmc">PMC4815357</ArticleId><ArticleId IdType="pubmed">27065999</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang L., Gu S., Gong Y., Li B., Lu H., Li Q., Zhang R., Gao X., Wu Z., Zhang J., et al. Clinical Significance of the Correlation between Changes in the Major Intestinal Bacteria Species and COVID-19 Severity. Engineering. 2020;6:1178&#x2013;1184. doi: 10.1016/j.eng.2020.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eng.2020.05.013</ArticleId><ArticleId IdType="pmc">PMC7832131</ArticleId><ArticleId IdType="pubmed">33520333</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao W., Zhang G., Wang X., Guo M., Zeng W., Xu Z., Cao D., Pan A., Wang Y., Zhang K., et al. Analysis of the Intestinal Microbiota in COVID-19 Patients and Its Correlation with the Inflammatory Factor IL-18. Med. Microecol. 2020;5:100023. doi: 10.1016/j.medmic.2020.100023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medmic.2020.100023</ArticleId><ArticleId IdType="pmc">PMC7832617</ArticleId><ArticleId IdType="pubmed">34173452</ArticleId></ArticleIdList></Reference><Reference><Citation>Louis P., Flint H.J. Diversity, Metabolism and Microbial Ecology of Butyrate-Producing Bacteria from the Human Large Intestine. FEMS Microbiol. Lett. 2009;294:1&#x2013;8. doi: 10.1111/j.1574-6968.2009.01514.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6968.2009.01514.x</ArticleId><ArticleId IdType="pubmed">19222573</ArticleId></ArticleIdList></Reference><Reference><Citation>Andoh A., Tsujikawa T., Fujiyama Y. Role of Dietary Fiber and Short-Chain Fatty Acids in the Colon. Curr. Pharm. Des. 2003;9:347&#x2013;358. doi: 10.2174/1381612033391973.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612033391973</ArticleId><ArticleId IdType="pubmed">12570825</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokol H., Pigneur B., Watterlot L., Lakhdari O., Berm&#xfa;dez-Humar&#xe1;n L.G., Gratadoux J.-J., Blugeon S., Bridonneau C., Furet J.-P., Corthier G., et al. Faecalibacterium Prausnitzii Is an Anti-Inflammatory Commensal Bacterium Identified by Gut Microbiota Analysis of Crohn Disease Patients. Proc. Natl. Acad. Sci. USA. 2008;105:16731&#x2013;16736. doi: 10.1073/pnas.0804812105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0804812105</ArticleId><ArticleId IdType="pmc">PMC2575488</ArticleId><ArticleId IdType="pubmed">18936492</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen J.M. The Immune Response to Prevotella Bacteria in Chronic Inflammatory Disease. Immunology. 2017;151:363&#x2013;374. doi: 10.1111/imm.12760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12760</ArticleId><ArticleId IdType="pmc">PMC5506432</ArticleId><ArticleId IdType="pubmed">28542929</ArticleId></ArticleIdList></Reference><Reference><Citation>Novick D., Kim S., Kaplanski G., Dinarello C.A. Interleukin-18, More than a Th1 Cytokine. Semin. Immunol. 2013;25:439&#x2013;448. doi: 10.1016/j.smim.2013.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2013.10.014</ArticleId><ArticleId IdType="pubmed">24275602</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceramella J., Iacopetta D., Sinicropi M.S., Andreu I., Mariconda A., Saturnino C., Giuzio F., Longo P., Aquaro S., Catalano A. Drugs for COVID-19: An Update. Molecules. 2022;27:8562. doi: 10.3390/molecules27238562.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27238562</ArticleId><ArticleId IdType="pmc">PMC9740261</ArticleId><ArticleId IdType="pubmed">36500655</ArticleId></ArticleIdList></Reference><Reference><Citation>Granata G., Schiavone F., Pipitone G., Taglietti F., Petrosillo N. Antibiotics Use in COVID-19 Patients: A Systematic Literature Review. J. Clin. Med. 2022;11:7207. doi: 10.3390/jcm11237207.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11237207</ArticleId><ArticleId IdType="pmc">PMC9739751</ArticleId><ArticleId IdType="pubmed">36498781</ArticleId></ArticleIdList></Reference><Reference><Citation>Groves H.T., Cuthbertson L., James P., Moffatt M.F., Cox M.J., Tregoning J.S. Respiratory Disease Following Viral Lung Infection Alters the Murine Gut Microbiota. Front. Immunol. 2018;9:182. doi: 10.3389/fimmu.2018.00182.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00182</ArticleId><ArticleId IdType="pmc">PMC5816042</ArticleId><ArticleId IdType="pubmed">29483910</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding J.N., Siefker D., Vu L., You D., DeVincenzo J., Pierre J., Cormier S.A. Altered Gut Microbiota in Infants Is Associated with Respiratory Syncytial Virus Disease Severity. BMC Microbiol. 2020;20:140. doi: 10.1186/s12866-020-01816-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12866-020-01816-5</ArticleId><ArticleId IdType="pmc">PMC7268675</ArticleId><ArticleId IdType="pubmed">32487019</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu H., Zhang C., Qian G., Hu X., Zhang H., Chen C., Liang W., Gao H., Yang Y., Li L. An Analysis of Microbiota-Targeted Therapies in Patients with Avian Influenza Virus Subtype H7N9 Infection. BMC Infect. Dis. 2014;14:359. doi: 10.1186/1471-2334-14-359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-14-359</ArticleId><ArticleId IdType="pmc">PMC4107951</ArticleId><ArticleId IdType="pubmed">24990477</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin N., Zheng B., Yao J., Guo L., Zuo J., Wu L., Zhou J., Liu L., Guo J., Ni S., et al. Influence of H7N9 Virus Infection and Associated Treatment on Human Gut Microbiota. Sci. Rep. 2015;5:14771. doi: 10.1038/srep14771.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep14771</ArticleId><ArticleId IdType="pmc">PMC4614822</ArticleId><ArticleId IdType="pubmed">26490635</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., Kr&#xfc;ger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.-H., Nitsche A., et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181:271&#x2013;280.e8. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou X., Liu Y., Lei X., Li P., Mi D., Ren L., Guo L., Guo R., Chen T., Hu J., et al. Characterization of Spike Glycoprotein of SARS-CoV-2 on Virus Entry and Its Immune Cross-Reactivity with SARS-CoV. Nat. Commun. 2020;11:1620. doi: 10.1038/s41467-020-15562-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-15562-9</ArticleId><ArticleId IdType="pmc">PMC7100515</ArticleId><ArticleId IdType="pubmed">32221306</ArticleId></ArticleIdList></Reference><Reference><Citation>Geva-Zatorsky N., Sefik E., Kua L., Pasman L., Tan T.G., Ortiz-Lopez A., Yanortsang T.B., Yang L., Jupp R., Mathis D., et al. Mining the Human Gut Microbiota for Immunomodulatory Organisms. Cell. 2017;168:928&#x2013;943.e11. doi: 10.1016/j.cell.2017.01.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.01.022</ArticleId><ArticleId IdType="pmc">PMC7774263</ArticleId><ArticleId IdType="pubmed">28215708</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadi Badi S., Malek A., Paolini A., Rouhollahi Masoumi M., Seyedi S.A., Amanzadeh A., Masotti A., Khatami S., Siadat S.D. Downregulation of ACE, AGTR1, and ACE2 Genes Mediating SARS-CoV-2 Pathogenesis by Gut Microbiota Members and Their Postbiotics on Caco-2 Cells. Microb. Pathog. 2022;173:105798. doi: 10.1016/j.micpath.2022.105798.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2022.105798</ArticleId><ArticleId IdType="pmc">PMC9511898</ArticleId><ArticleId IdType="pubmed">36174833</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y., Wang B., Gao H., Gao L., Hua R., Xu J.-D. ACE2 in the Gut: The Center of the 2019-nCoV Infected Pathology. Front. Mol. Biosci. 2021;8:708336. doi: 10.3389/fmolb.2021.708336.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2021.708336</ArticleId><ArticleId IdType="pmc">PMC8493804</ArticleId><ArticleId IdType="pubmed">34631794</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheon S.Y., Koo B.-N. Inflammatory Response in COVID-19 Patients Resulting from the Interaction of the Inflammasome and SARS-CoV-2. Int. J. Mol. Sci. 2021;22:7914. doi: 10.3390/ijms22157914.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22157914</ArticleId><ArticleId IdType="pmc">PMC8348456</ArticleId><ArticleId IdType="pubmed">34360684</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo J., Groer M., Dutra S., Sarkar A., McSkimming D. Gut Microbiota and Immune System Interactions. Microorganisms. 2020;8:1587. doi: 10.3390/microorganisms8101587.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms8101587</ArticleId><ArticleId IdType="pmc">PMC7602490</ArticleId><ArticleId IdType="pubmed">33076307</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyerstedt S., Casaro E.B., Rangel &#xc9;.B. COVID-19: Angiotensin-Converting Enzyme 2 (ACE2) Expression and Tissue Susceptibility to SARS-CoV-2 Infection. Eur. J. Clin. Microbiol. Infect. Dis. 2021;40:905&#x2013;919. doi: 10.1007/s10096-020-04138-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-020-04138-6</ArticleId><ArticleId IdType="pmc">PMC7778857</ArticleId><ArticleId IdType="pubmed">33389262</ArticleId></ArticleIdList></Reference><Reference><Citation>De Maio F., Ianiro G., Coppola G., Santopaolo F., Abbate V., Bianco D.M., Del Zompo F., De Matteis G., Leo M., Nesci A., et al. Improved Gut Microbiota Features after the Resolution of SARS-CoV-2 Infection. Gut Pathog. 2021;13:62. doi: 10.1186/s13099-021-00459-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13099-021-00459-9</ArticleId><ArticleId IdType="pmc">PMC8520333</ArticleId><ArticleId IdType="pubmed">34656179</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Q., Liu Q., Lau R.I., Zhang J., Xu Z., Yeoh Y.K., Leung T.W.H., Tang W., Zhang L., Liang J.Q.Y., et al. Faecal Microbiome-Based Machine Learning for Multi-Class Disease Diagnosis. Nat. Commun. 2022;13:6818. doi: 10.1038/s41467-022-34405-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34405-3</ArticleId><ArticleId IdType="pmc">PMC9649010</ArticleId><ArticleId IdType="pubmed">36357393</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Wu G., Zhao L., Wang W. Nutritional Modulation of Gut Microbiota Alleviates Severe Gastrointestinal Symptoms in a Patient with Post-Acute COVID-19 Syndrome. mBio. 2022;13:e03801-21. doi: 10.1128/mbio.03801-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.03801-21</ArticleId><ArticleId IdType="pmc">PMC9040862</ArticleId><ArticleId IdType="pubmed">35254129</ArticleId></ArticleIdList></Reference><Reference><Citation>Zurabov F.M., Chernevskaya E.A., Beloborodova N.V., Zurabov A.Y., Petrova M.V., Yadgarov M.Y., Popova V.M., Fatuev O.E., Zakharchenko V.E., Gurkova M.M., et al. Bacteriophage Cocktails in the Post-COVID Rehabilitation. Viruses. 2022;14:2614. doi: 10.3390/v14122614.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14122614</ArticleId><ArticleId IdType="pmc">PMC9783051</ArticleId><ArticleId IdType="pubmed">36560618</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Su Q., Zhang F., Tun H.M., Mak J.W.Y., Lui G.C.-Y., Ng S.S.S., Ching J.Y.L., Li A., Lu W., et al. Multi-Kingdom Gut Microbiota Analyses Define COVID-19 Severity and Post-Acute COVID-19 Syndrome. Nat. Commun. 2022;13:6806. doi: 10.1038/s41467-022-34535-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34535-8</ArticleId><ArticleId IdType="pmc">PMC9648868</ArticleId><ArticleId IdType="pubmed">36357381</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X., Zhang W., Guo M., Xiao C., Fu Z., Yu S., Jiang L., Wang S., Ling Y., Liu F., et al. Integrated Analysis of Gut Microbiome and Host Immune Responses in COVID-19. Front. Med. 2022;16:263&#x2013;275. doi: 10.1007/s11684-022-0921-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11684-022-0921-6</ArticleId><ArticleId IdType="pmc">PMC8902486</ArticleId><ArticleId IdType="pubmed">35258762</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D., Zhou Y., Ma Y., Chen P., Tang J., Yang B., Li H., Liang M., Xue Y., Liu Y., et al. Gut Microbiota Dysbiosis Correlates With Long COVID-19 at One-Year After Discharge. J. Korean Med. Sci. 2023;38:e120. doi: 10.3346/jkms.2023.38.e120.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2023.38.e120</ArticleId><ArticleId IdType="pmc">PMC10111044</ArticleId><ArticleId IdType="pubmed">37069814</ArticleId></ArticleIdList></Reference><Reference><Citation>Trottein F., Sokol H. Potential Causes and Consequences of Gastrointestinal Disorders during a SARS-CoV-2 Infection. Cell Rep. 2020;32:107915. doi: 10.1016/j.celrep.2020.107915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.107915</ArticleId><ArticleId IdType="pmc">PMC7332457</ArticleId><ArticleId IdType="pubmed">32649864</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorson A.E., Deen G.F., Bernstein K.T., Liu W.J., Yamba F., Habib N., Sesay F.R., Gaillard P., Massaquoi T.A., McDonald S.L.R., et al. Persistence of Ebola Virus in Semen among Ebola Virus Disease Survivors in Sierra Leone: A Cohort Study of Frequency, Duration, and Risk Factors. PLoS Med. 2021;18:e1003273. doi: 10.1371/journal.pmed.1003273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003273</ArticleId><ArticleId IdType="pmc">PMC7875361</ArticleId><ArticleId IdType="pubmed">33566817</ArticleId></ArticleIdList></Reference><Reference><Citation>Aid M., Abbink P., Larocca R.A., Boyd M., Nityanandam R., Nanayakkara O., Martinot A.J., Moseley E.T., Blass E., Borducchi E.N., et al. Zika Virus Persistence in the Central Nervous System and Lymph Nodes of Rhesus Monkeys. Cell. 2017;169:610&#x2013;620.e14. doi: 10.1016/j.cell.2017.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.04.008</ArticleId><ArticleId IdType="pmc">PMC5426912</ArticleId><ArticleId IdType="pubmed">28457610</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh K.A., Jordan K., Clyne B., Rohde D., Drummond L., Byrne P., Ahern S., Carty P.G., O&#x2019;Brien K.K., O&#x2019;Murchu E., et al. SARS-CoV-2 Detection, Viral Load and Infectivity over the Course of an Infection. J. Infect. 2020;81:357&#x2013;371. doi: 10.1016/j.jinf.2020.06.067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.06.067</ArticleId><ArticleId IdType="pmc">PMC7323671</ArticleId><ArticleId IdType="pubmed">32615199</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E., Xie Y., Al-Aly Z. Long-Term Gastrointestinal Outcomes of COVID-19. Nat. Commun. 2023;14:983. doi: 10.1038/s41467-023-36223-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-36223-7</ArticleId><ArticleId IdType="pmc">PMC9992516</ArticleId><ArticleId IdType="pubmed">36882400</ArticleId></ArticleIdList></Reference><Reference><Citation>Filip R., Gheorghita Puscaselu R., Anchidin-Norocel L., Dimian M., Savage W.K. Global Challenges to Public Health Care Systems during the COVID-19 Pandemic: A Review of Pandemic Measures and Problems. J. Pers. Med. 2022;12:1295. doi: 10.3390/jpm12081295.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12081295</ArticleId><ArticleId IdType="pmc">PMC9409667</ArticleId><ArticleId IdType="pubmed">36013244</ArticleId></ArticleIdList></Reference><Reference><Citation>Farsi Y., Tahvildari A., Arbabi M., Vazife F., Sechi L.A., Shahidi Bonjar A.H., Jamshidi P., Nasiri M.J., Mirsaeidi M. Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review. Front. Cell. Infect. Microbiol. 2022;12:804644. doi: 10.3389/fcimb.2022.804644.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.804644</ArticleId><ArticleId IdType="pmc">PMC8930898</ArticleId><ArticleId IdType="pubmed">35310853</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Garrett S., Sun J. Gastrointestinal Symptoms, Pathophysiology, and Treatment in COVID-19. Genes Dis. 2020;8:385&#x2013;400. doi: 10.1016/j.gendis.2020.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gendis.2020.08.013</ArticleId><ArticleId IdType="pmc">PMC7836435</ArticleId><ArticleId IdType="pubmed">33521210</ArticleId></ArticleIdList></Reference><Reference><Citation>De R., Dutta S. Role of the Microbiome in the Pathogenesis of COVID-19. Front. Cell. Infect. Microbiol. 2022;12:736397. doi: 10.3389/fcimb.2022.736397.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.736397</ArticleId><ArticleId IdType="pmc">PMC9009446</ArticleId><ArticleId IdType="pubmed">35433495</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadopoulou G., Manoloudi E., Repousi N., Skoura L., Hurst T., Karamitros T. Molecular and Clinical Prognostic Biomarkers of COVID-19 Severity and Persistence. Pathogens. 2022;11:311. doi: 10.3390/pathogens11030311.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11030311</ArticleId><ArticleId IdType="pmc">PMC8948624</ArticleId><ArticleId IdType="pubmed">35335635</ArticleId></ArticleIdList></Reference><Reference><Citation>Neag M.A., Vulturar D.-M., Gherman D., Burlacu C.-C., Todea D.A., Buzoianu A.D. Gastrointestinal Microbiota: A Predictor of COVID-19 Severity? World, J. Gastroenterol. 2022;28:6328&#x2013;6344. doi: 10.3748/wjg.v28.i45.6328.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v28.i45.6328</ArticleId><ArticleId IdType="pmc">PMC9753053</ArticleId><ArticleId IdType="pubmed">36533107</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzarelli A., Giancola M.L., Fontana A., Piselli P., Binda E., Trivieri N., Mencarelli G., Marchioni L., Vulcano A., De Giuli C., et al. Gut Microbiota Composition in COVID-19 Hospitalized Patients with Mild or Severe Symptoms. Front. Microbiol. 2022;13 doi: 10.3389/fmicb.2022.1049215.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.1049215</ArticleId><ArticleId IdType="pmc">PMC9763305</ArticleId><ArticleId IdType="pubmed">36560946</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsayed A.R., Abed A., Khader H.A., Al-Shdifat L.M.H., Hasoun L., Al-Rshaidat M.M.D., Alkhatib M., Zihlif M. Molecular Accounting and Profiling of Human Respiratory Microbial Communities: Toward Precision Medicine by Targeting the Respiratory Microbiome for Disease Diagnosis and Treatment. Int. J. Mol. Sci. 2023;24:4086. doi: 10.3390/ijms24044086.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24044086</ArticleId><ArticleId IdType="pmc">PMC9966333</ArticleId><ArticleId IdType="pubmed">36835503</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu T., Jin J., Chen M., Chen Y. The Impact of Infection with COVID-19 on the Respiratory Microbiome: A Narrative Review. Virulence. 2022;13:1076&#x2013;1087. doi: 10.1080/21505594.2022.2090071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21505594.2022.2090071</ArticleId><ArticleId IdType="pmc">PMC9794016</ArticleId><ArticleId IdType="pubmed">35763685</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren L., Wang Y., Zhong J., Li X., Xiao Y., Li J., Yang J., Fan G., Guo L., Shen Z., et al. Dynamics of the Upper Respiratory Tract Microbiota and Its Association with Mortality in COVID-19. Am. J. Respir. Crit. Care Med. 2021;204:1379&#x2013;1390. doi: 10.1164/rccm.202103-0814OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202103-0814OC</ArticleId><ArticleId IdType="pmc">PMC8865718</ArticleId><ArticleId IdType="pubmed">34534435</ArticleId></ArticleIdList></Reference><Reference><Citation>Dur&#xe1;n-Manuel E.M., Loyola-Cruz M.&#xc1;., Cruz-Cruz C., Ib&#xe1;&#xf1;ez-Cervantes G., Gayt&#xe1;n-Cervantes J., Gonz&#xe1;lez-Torres C., Quiroga-Vargas E., Calzada-Mendoza C.C., Cure&#xf1;o-D&#xed;az M.A., Fern&#xe1;ndez-S&#xe1;nchez V., et al. Massive Sequencing of the V3-V4 Hypervariable Region of Bronchoalveolar Lavage from Patients with COVID-19 and VAP Reveals the Collapse of the Pulmonary Microbiota. J. Med. Microbiol. 2022;71 doi: 10.1099/jmm.0.001634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.001634</ArticleId><ArticleId IdType="pubmed">36748614</ArticleId></ArticleIdList></Reference><Reference><Citation>Merenstein C., Liang G., Whiteside S.A., Cobi&#xe1;n-G&#xfc;emes A.G., Merlino M.S., Taylor L.J., Glascock A., Bittinger K., Tanes C., Graham-Wooten J., et al. Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome. mBio. 2021;12:e01777-21. doi: 10.1128/mBio.01777-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01777-21</ArticleId><ArticleId IdType="pmc">PMC8406335</ArticleId><ArticleId IdType="pubmed">34399607</ArticleId></ArticleIdList></Reference><Reference><Citation>Ojala T., Kankuri E., Kankainen M. Understanding Human Health through Metatranscriptomics. Trends Mol. Med. 2023;29:376&#x2013;389. doi: 10.1016/j.molmed.2023.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2023.02.002</ArticleId><ArticleId IdType="pubmed">36842848</ArticleId></ArticleIdList></Reference><Reference><Citation>Athanasopoulou K., Adamopoulos P.G., Scorilas A. Unveiling the Human Gastrointestinal Tract Microbiome: The Past, Present, and Future of Metagenomics. Biomedicines. 2023;11:827. doi: 10.3390/biomedicines11030827.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11030827</ArticleId><ArticleId IdType="pmc">PMC10045138</ArticleId><ArticleId IdType="pubmed">36979806</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma&#x144;kowska-Wierzbicka D., Zuraszek J., Wierzbicka A., Gabryel M., Mahadea D., Baturo A., Zakerska-Banaszak O., Slomski R., Skrzypczak-Zielinska M., Dobrowolska A. Alterations in Gut Microbiota Composition in Patients with COVID-19: A Pilot Study of Whole Hypervariable 16S rRNA Gene Sequencing. Biomedicines. 2023;11:367. doi: 10.3390/biomedicines11020367.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11020367</ArticleId><ArticleId IdType="pmc">PMC9953267</ArticleId><ArticleId IdType="pubmed">36830905</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti V., Corbi G., Sabbatino F., De Pascale D., Sellitto C., Stefanelli B., Bertini N., De Simone M., Liguori L., Di Paola I., et al. Long COVID: Clinical Framing, Biomarkers, and Therapeutic Approaches. J. Pers. Med. 2023;13:334. doi: 10.3390/jpm13020334.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm13020334</ArticleId><ArticleId IdType="pmc">PMC9959656</ArticleId><ArticleId IdType="pubmed">36836568</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-L&#xe1;zaro D., S&#xe1;nchez-Serrano N., Mielgo-Ayuso J., Garc&#xed;a-Hern&#xe1;ndez J.L., Gonz&#xe1;lez-Bernal J.J., Seco-Calvo J. Long COVID a New Derivative in the Chaos of SARS-CoV-2 Infection: The Emergent Pandemic? J. Clin. Med. 2021;10:5799. doi: 10.3390/jcm10245799.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10245799</ArticleId><ArticleId IdType="pmc">PMC8708091</ArticleId><ArticleId IdType="pubmed">34945095</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarpellini E., Tack J. Post-COVID-19 Gastro-Intestinal Disturbances. Rev. Recent Clin. Trials. 2023;18:34&#x2013;40. doi: 10.2174/1574887118666221201104833.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1574887118666221201104833</ArticleId><ArticleId IdType="pubmed">36464877</ArticleId></ArticleIdList></Reference><Reference><Citation>Xavier-Santos D., Padilha M., Fabiano G.A., Vinderola G., Gomes Cruz A., Sivieri K., Costa Antunes A.E. Evidences and Perspectives of the Use of Probiotics, Prebiotics, Synbiotics, and Postbiotics as Adjuvants for Prevention and Treatment of COVID-19: A Bibliometric Analysis and Systematic Review. Trends Food Sci. Technol. 2022;120:174&#x2013;192. doi: 10.1016/j.tifs.2021.12.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tifs.2021.12.033</ArticleId><ArticleId IdType="pmc">PMC8720301</ArticleId><ArticleId IdType="pubmed">35002079</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazemian N., Kao D., Pakpour S. Fecal Microbiota Transplantation during and Post-COVID-19 Pandemic. Int. J. Mol. Sci. 2021;22:3004. doi: 10.3390/ijms22063004.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22063004</ArticleId><ArticleId IdType="pmc">PMC7998826</ArticleId><ArticleId IdType="pubmed">33809421</ArticleId></ArticleIdList></Reference><Reference><Citation>Bili&#x144;ski J., Winter K., Jasi&#x144;ski M., Szcz&#x119;&#x15b; A., Bilinska N., Mullish B.H., Ma&#x142;ecka-Panas E., Basak G.W. Rapid Resolution of COVID-19 after Faecal Microbiota Transplantation. Gut. 2022;71:230&#x2013;232. doi: 10.1136/gutjnl-2021-325010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325010</ArticleId><ArticleId IdType="pubmed">34230217</ArticleId></ArticleIdList></Reference><Reference><Citation>Ianiro G., Mullish B.H., Kelly C.R., Sokol H., Kassam Z., Ng S.C., Fischer M., Allegretti J.R., Masucci L., Zhang F., et al. Screening of Faecal Microbiota Transplant Donors during the COVID-19 Outbreak: Suggestions for Urgent Updates from an International Expert Panel. Lancet Gastroenterol. Hepatol. 2020;5:430&#x2013;432. doi: 10.1016/S2468-1253(20)30082-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-1253(20)30082-0</ArticleId><ArticleId IdType="pmc">PMC7104244</ArticleId><ArticleId IdType="pubmed">32192627</ArticleId></ArticleIdList></Reference><Reference><Citation>Khaled J.M.A. Probiotics, Prebiotics, and COVID-19 Infection: A Review Article. Saudi, J. Biol. Sci. 2021;28:865&#x2013;869. doi: 10.1016/j.sjbs.2020.11.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sjbs.2020.11.025</ArticleId><ArticleId IdType="pmc">PMC7783823</ArticleId><ArticleId IdType="pubmed">33424377</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray M., Manjunath A., Halami P.M. Effect of Probiotics as an Immune Modulator for the Management of COVID-19. Arch. Microbiol. 2023;205:182. doi: 10.1007/s00203-023-03504-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00203-023-03504-0</ArticleId><ArticleId IdType="pmc">PMC10098245</ArticleId><ArticleId IdType="pubmed">37031431</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M., Zhang Y., Li C., Chang W., Zhang L. The Relationship between Gut Microbiota and COVID-19 Progression: New Insights into Immunopathogenesis and Treatment. Front. Immunol. 2023;14 doi: 10.3389/fimmu.2023.1180336.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1180336</ArticleId><ArticleId IdType="pmc">PMC10185909</ArticleId><ArticleId IdType="pubmed">37205106</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown J.A., Sanidad K.Z., Lucotti S., Lieber C.M., Cox R.M., Ananthanarayanan A., Basu S., Chen J., Shan M., Amir M., et al. Gut Microbiota-Derived Metabolites Confer Protection against SARS-CoV-2 Infection. Gut Microbes. 2022;14:2105609. doi: 10.1080/19490976.2022.2105609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2022.2105609</ArticleId><ArticleId IdType="pmc">PMC9348133</ArticleId><ArticleId IdType="pubmed">35915556</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballesteros R.V., G&#xe1;mez M.A., Macaya-Ten F., Mart&#xed;nez M.V., Tejedor A.V. An Uncommon Cause of Anterior ST-Segment Elevation. Eur. Heart, J. Case Rep. 2023;7:ytad299. doi: 10.1093/ehjcr/ytad299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjcr/ytad299</ArticleId><ArticleId IdType="pmc">PMC10347669</ArticleId><ArticleId IdType="pubmed">37457050</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>